Sort
23,748 grants matching “melanoma”
Investigating Transcriptional Elongation and Nuclear RNA Surveillance in Melanoma
$195,902Megan Leigh Insco · Dana-Farber Cancer Inst · K08 · FY2023 · CA
NEISSERIAL PORINS AND ANTIGEN PRESENTING CELL
$195,881Boston Medical Center · R01 · FY2001 · AI
Plasma DSC for early detection of disease and therapeutic efficacy in melanoma
$195,750Nichola C. Garbett · University Of Louisville · R21 · FY2014 · CA
Functional Imaging of Tumor-Associated Lymphatics
$195,750Sunkuk Kwon · University Of Texas Hlth Sci Ctr Houston · R21 · FY2012 · CA
SOUTHWEST ONCOLOGY GROUP
$195,704University Of Texas Hlth Sci Ctr San Ant · U10 · FY2003 · CA
Immunoregulatory Mechanisms of BiTE Efficacy in the Cold Neuroblastoma TME
$195,700James M Olson · Seattle Children'S Hospital · U01 · FY2024 · CA
Improving decision-making in patients with resectable melanoma and pre-existing autoimmune disease considering immune checkpoint inhibition
$195,646Maria De Los Angeles Lopez-Olivo · University Of Tx Md Anderson Can Ctr · K08 · FY2024 · CA
Regulation of Oncogene-Induced Senescence by Wnt-Signaling
$195,639Peter D. Adams · University Of Glasgow · R01 · FY2011 · CA
Novel hematopoietic humanized mouse model to study CAR-T therapy-associated cytokine release syndrome
$195,610Yong Fan · Allegheny-Singer Research Institute · R21 · FY2024 · OD
Protective roles of CTL responses to HIV-1 associated self epitope
$195,570Beth D. Jamieson-Karavodin · University Of California Los Angeles · R21 · FY2009 · AG
Adhesion Regulation of ERK Trafficking to the Nucleus
$195,569Andrew E Aplin · Thomas Jefferson University · R01 · FY2008 · GM
Data Bank & BioRepository
$195,508Christine B. Ambrosone · Roswell Park Cancer Institute Corp · P30 · FY2010 · CA
Mechanisms of autoimmune thyroid disease and the role of interferon-alpha
$195,498Jennifer Sophie Mammen · Johns Hopkins University · K23 · FY2017 · DK
Role of E2F1 in eugenol-mediated antiproliferative activity in melanoma cells
$195,480Rita Ghosh · University Of Texas Hlth Science Center · R21 · FY2008 · CA
TERT transcriptional deregulation in thyroid cancer progression
$195,480Inigo Landa-Lopez · Brigham And Women'S Hospital · K22 · FY2021 · CA
TERT transcriptional deregulation in thyroid cancer progression
$195,480Inigo Landa-Lopez · Brigham And Women'S Hospital · K22 · FY2022 · CA
A zebrafish model for studying orbital development and disease
$195,480Alon Kahana · University Of Michigan At Ann Arbor · K08 · FY2008 · EY
Effects of a Novel Phospho-STAT2 inhibitor for Treatment of Stage IV Melanoma
$195,391Amy Beth Heimberger · University Of Tx Md Anderson Can Ctr · P50 · FY2010 · CA
Discrete Sensor Devices for Determining Cancer Targets
$195,281Michael J Cima · Massachusetts Institute Of Technology · U54 · FY2011 · CA
Therapuetic Immune Targeting of EphA2 Expressed by Melanoma & Its Tumor-Associate
$195,261Walter J Storkus · University Of Pittsburgh At Pittsburgh · P50 · FY2012 · CA
TUMOR-TARGETING WITH NEW BORONATED PORPHYRINS
$195,251Maria Da Graca Henriques Vicente · Louisiana State Univ A&M Col Baton Rouge · R01 · FY2009 · CA
Mechanisms of non-genetic variation in melanoma
$195,134Salil Garg · Yale University · K08 · FY2023 · CA
Mechanisms of non-genetic variation in melanoma
$195,134Salil Garg · Massachusetts General Hospital · K08 · FY2020 · CA
Mechanisms of non-genetic variation in melanoma
$195,134Salil Garg · Yale University · K08 · FY2024 · CA
Mechanisms of non-genetic variation in melanoma
$195,134Salil Garg · Massachusetts General Hospital · K08 · FY2021 · CA